181 related articles for article (PubMed ID: 27064315)
21. Bioabsorbable steroid-eluting sinus stents for patients with refractory frontal diseases undergoing a revision Draf 3 procedure: a case series.
Huang Z; Huang Q; Zhou B; Ma J; Wang M; Dong Y
Acta Otolaryngol; 2019 Jul; 139(7):636-642. PubMed ID: 31124718
[No Abstract] [Full Text] [Related]
22. Complications Associated with PROPEL Mometasone Furoate Bioabsorbable Drug-eluting Sinus Stents From 2012 to 2020.
Shah VN; Pasick LJ; Benito DA; Ghiam MK; D'Aguillo C
Am J Rhinol Allergy; 2022 Mar; 36(2):185-190. PubMed ID: 34342518
[TBL] [Abstract][Full Text] [Related]
23. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis.
Han JK; Marple BF; Smith TL; Murr AH; Lanier BJ; Stambaugh JW; Mugglin AS
Int Forum Allergy Rhinol; 2012; 2(4):271-9. PubMed ID: 22550039
[TBL] [Abstract][Full Text] [Related]
24. Association of Comorbid Asthma and the Efficacy of Bioabsorbable Steroid-eluting Sinus Stents Implanted After Endoscopic Sinus Surgery in Patients with Chronic Rhinosinusitis with Nasal Polyps.
Huang A; Li T; Li MS; Huang ZX; Wang DH; Cheng L; Zhou B; Wang H; Liu Z
Curr Med Sci; 2023 Oct; 43(5):1005-1012. PubMed ID: 37828371
[TBL] [Abstract][Full Text] [Related]
25. Endoscopic polypectomy in the clinic: a pilot cost-effectiveness analysis.
Rudmik L; Smith KA; Kilty S
Clin Otolaryngol; 2016 Apr; 41(2):110-7. PubMed ID: 26053107
[TBL] [Abstract][Full Text] [Related]
26. Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis.
Rudmik L; Smith TL; Mace JC; Schlosser RJ; Hwang PH; Soler ZM
Laryngoscope; 2016 Mar; 126(3):570-4. PubMed ID: 26371457
[TBL] [Abstract][Full Text] [Related]
27. The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery.
Dautremont JF; Mechor B; Rudmik L
Otolaryngol Head Neck Surg; 2014 Apr; 150(4):689-95. PubMed ID: 24482348
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a steroid releasing sinus implant for the treatment of patients undergoing frontal sinus surgery for chronic rhinosinusitis.
Bury S; Singh A
Expert Rev Med Devices; 2017 Feb; 14(2):93-101. PubMed ID: 28092201
[TBL] [Abstract][Full Text] [Related]
29. Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the US.
Lodise T; Guo A; Yang M; Cook EE; Song W; Yang D; Wang Q; Zhao A; Bochan M
Adv Ther; 2023 Jun; 40(6):2801-2819. PubMed ID: 37093360
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of a bioabsorbable fluticasone propionate-eluting sinus dressing in postoperative management of endoscopic sinus surgery: a randomized clinical trial.
Adriaensen GFJPM; Lim KH; Fokkens WJ
Int Forum Allergy Rhinol; 2017 Aug; 7(8):813-820. PubMed ID: 28558147
[TBL] [Abstract][Full Text] [Related]
31. A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis.
Park SH; Han X; Lobo F; Kratochvil D; Patel D
J Med Econ; 2020 Jun; 23(6):624-630. PubMed ID: 32075453
[No Abstract] [Full Text] [Related]
32. Cost effectiveness and budget impact of natalizumab in patients with relapsing multiple sclerosis.
Chiao E; Meyer K
Curr Med Res Opin; 2009 Jun; 25(6):1445-54. PubMed ID: 19422279
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening.
Smith TL; Singh A; Luong A; Ow RA; Shotts SD; Sautter NB; Han JK; Stambaugh J; Raman A
Laryngoscope; 2016 Dec; 126(12):2659-2664. PubMed ID: 27363723
[TBL] [Abstract][Full Text] [Related]
34. Early postoperative care following endoscopic sinus surgery: an evidence-based review with recommendations.
Rudmik L; Soler ZM; Orlandi RR; Stewart MG; Bhattacharyya N; Kennedy DW; Smith TL
Int Forum Allergy Rhinol; 2011; 1(6):417-30. PubMed ID: 22144050
[TBL] [Abstract][Full Text] [Related]
35. Budget impact model of a 5-grass sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis.
Ivanova JI; Kelkar S; King S; Birnbaum HG; Hocker S; Phipps R; Lankow R
J Med Econ; 2015; 18(11):909-18. PubMed ID: 26481690
[TBL] [Abstract][Full Text] [Related]
36. Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization.
Benninger MS; Sindwani R; Holy CE; Hopkins C
Otolaryngol Head Neck Surg; 2015 Mar; 152(3):546-52. PubMed ID: 25573680
[TBL] [Abstract][Full Text] [Related]
37. Impact of residual ethmoid cells on postoperative course after endoscopic sinus surgery for chronic rhinosinusitis.
Okushi T; Mori E; Nakayama T; Asaka D; Matsuwaki Y; Ota K; Chiba S; Moriyama H; Otori N
Auris Nasus Larynx; 2012 Oct; 39(5):484-9. PubMed ID: 22088258
[TBL] [Abstract][Full Text] [Related]
38. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants.
Marple BF; Smith TL; Han JK; Gould AR; Jampel HD; Stambaugh JW; Mugglin AS
Otolaryngol Head Neck Surg; 2012 Jun; 146(6):1004-11. PubMed ID: 22301107
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of steroid-eluting stents in management of chronic rhinosinusitis after endoscopic sinus surgery: updated meta-analysis.
Goshtasbi K; Abouzari M; Abiri A; Yasaka T; Sahyouni R; Bitner B; Tajudeen BA; Kuan EC
Int Forum Allergy Rhinol; 2019 Dec; 9(12):1443-1450. PubMed ID: 31539461
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic sinus surgery for chronic rhinosinusitis in patients previously treated for sinonasal malignancy.
Gray ST; Sadow PM; Lin DT; Sedaghat AR
Laryngoscope; 2016 Feb; 126(2):304-15. PubMed ID: 26309057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
